课题基金 / 基金详情

OROTATE PHOSPHORIBOSYLTRANSFERASE--STRUCTURE & MECHANISM

OROTATE PHOSPHORIBOSYLTRANSFERASE--STRUCTURE & MECHANISM
乳清酸磷酸核糖基转移酶--结构
批准号:
2186120
负责人:
CHARLES T. GRUBMEYER
金额:
$28.28万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1996-07-31

项目摘要

项目成果

CHARLES T. GRUBMEYER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This collaborative project will provide, for the first time, a detailed view of the structure and function of the phosphoribosyltransferases (PRTases), the enzymes involved in nucleotide formation. These enzymes are targets for anticancer chemotherapies, and their dysfunction is the origin of several metabolic disorders including Lesch-Nyhan disease. Despite their key metabolic role and pharmacological significance, no three- dimensional structures are known for these enzymes, and mechanistic analysis is limited to scattered observations on individual enzymes of the group. We have chosen orotate phosphoribosyltransferase (OPRTase) as the subject for our comprehensive study because of its small size and kinetic tractability. The enzyme catalyzes the nucleotide-forming step in de novo synthesis of pyrimidine nucleotides (UTP, TTP and CTP), and is a target for chemotherapy based on lethal synthesis from the anticancer drug 5- fluorouracil. Lack of OPRTase, either hereditary or drug-induced, leads to orotic acidurea. We have cloned, sequenced, and overexpressed the OPRTase (pyrE) gene from Salmonella typhimurium, and purified the resultant enzyme to homogeneity. The enzyme crystallizes readily in a form eminently suitable for x-ray crystallographic studies, and diffracts to better than 2.0 A resolution. A heavy atom derivative has been found. The system is poised for detailed investigations of the type described below. Our studies employ kinetic isotope effects and positional isotope exchange (PIX) to study the nature of the transition state for the reaction, providing important information for future inhibitor design. The mechanism is further explored using pH studies to localize enzymic proton acceptor/donor groups involved in catalysis. The three-dimensional structure of OPRTase will be determined to high resolution, and used to model the structure of the closely similar OPRTase domain of the pharmacologically important human UMP synthase. Using the structure and proposed mechanism, a series of modification/mutagenesis experiments is planned to explore the origin of the substrate specificity exhibited by the PRTases, and OPRTase in particular. We expect that the structural information generated will allow predictions of other PRTase structures, and that the principles of catalysis that we uncover will hold for other PRTases as well.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE, MECHANISM, AND INHIBITOR DESIGN FOR HGPRT
  • 批准号:
    2191040
  • 项目类别:
  • 资助金额:
    $27.76万
  • 财政年份:
    1995
  • 负责人:
    CHARLES T. GRUBMEYER
  • 依托单位:
STRUCTURE, MECHANISM, AND INHIBITOR DESIGN FOR HGPRT
  • 批准号:
    2191041
  • 项目类别:
  • 资助金额:
    $28.62万
  • 财政年份:
    1995
  • 负责人:
    CHARLES T. GRUBMEYER
  • 依托单位:
STRUCTURE, MECHANISM, AND INHIBITOR DESIGN FOR HGPRT
  • 批准号:
    2519030
  • 项目类别:
  • 资助金额:
    $28.44万
  • 财政年份:
    1995
  • 负责人:
    CHARLES T. GRUBMEYER
  • 依托单位:
OROTATE PHOSPHORIBOSYLTRANSFERASE--MECHANISM
  • 批准号:
    6342862
  • 项目类别:
  • 资助金额:
    $33.22万
  • 财政年份:
    1992
  • 负责人:
    CHARLES T. GRUBMEYER
  • 依托单位: